A Sleeping Beauty transposon-mediated screen identifies murine susceptibility genes for adenomatous polyposis coli (Apc)-dependent intestinal tumorigenesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 14, 2011, Pages 5765-5770

  Starr, Timothy K ^a   Scott, Patricia M ^a   Marsh, Benjamin M ^a   Zhao, Lei ^a   Than, Bich L N ^a   O'Sullivan, M Gerard ^a,b   Sarver, Aaron L ^c   Dupuy, Adam J ^d   Largaespada, David A ^a   Cormier, Robert T ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

Cancer gene discovery; Transgenic mice

Indexed keywords

APC PROTEIN; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL PROLIFERATION; CELL VIABILITY; COLON CARCINOGENESIS; COLON POLYPOSIS; COLORECTAL CANCER; CONFERENCE PAPER; CONTROLLED STUDY; GENE LOCUS; GENE MUTATION; GENETIC SCREENING; MOUSE; MUTAGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TRANSPOSON;

MURINAE; MUS; MUS MUSCULUS;

EID: 79954992392     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1018012108     Document Type: Article

References (42)

1. Grady WM, Markowitz SD (2002) Genetic and epigenetic alterations in colon cancer. Annu Rev Genomics Hum Genet 3:101-128. (Pubitemid 35217432)
2. Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y (2006) Colorectal cancer: Genetics of development and metastasis. J Gastroenterol 41:185-192.
3. Wood LD, et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science 318:1108-1113. (Pubitemid 350134889)
4. Moser AR, Pitot HC, Dove WF (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247:322-324.
5. Su LK, et al. (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256:668-670.
6. Fodde R (2002) The APC gene in colorectal cancer. Eur J Cancer 38:867-871. (Pubitemid 34442313)
7. Dietrich WF, et al. (1993) Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75:631-639. (Pubitemid 23346362)
8. Cormier RT, et al. (1997) Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat Genet 17:88-91. (Pubitemid 27377538)
9. Levy DB, et al. (1994) Inactivation of both APC alleles in human and mouse tumors. Cancer Res 54:5953-5958. (Pubitemid 24375233)
10. Luongo C, Moser AR, Gledhill S, Dove WF (1994) Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res 54:5947-5952. (Pubitemid 24375232)
11. Haigis KM, Dove WF (2003) A Robertsonian translocation suppresses a somatic recombination pathway to loss of heterozygosity. Nat Genet 33:33-39. (Pubitemid 36068679)
12. Starr TK, et al. (2009) A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science 323:1747-1750.
13. Powell SM, et al. (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359:235-237.
14. Collier LS, Carlson CM, Ravimohan S, Dupuy AJ, Largaespada DA (2005) Cancer gene discovery using Sleeping Beauty transposon-based somatic mutagenesis in the mouse. Nature 436:272-276. (Pubitemid 41021279)
15. Zambrowicz BP, et al. (1997) Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc Natl Acad Sci USA 94:3789-3794. (Pubitemid 27180451)
16. Dupuy AJ, et al. (2009) A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice. Cancer Res 69:8150-8156.
17. el Marjou F, et al. (2004) Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis 39: 186-193. (Pubitemid 39079517)
18. McAlpine CA, Barak Y, Matise I, Cormier RT (2006) Intestinal-specific PPARgamma deficiency enhances tumorigenesis in ApcMin/+ mice. Int J Cancer 119:2339-2346. (Pubitemid 44546953)
19. Fodde R, Smits R (2001) Disease model: Familial adenomatous polyposis. Trends Mol Med 7:369-373. (Pubitemid 32735023)
20. Mueller PR, Wold B (1989) In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. Science 246:780-786. (Pubitemid 19279168)
21. Keng VW, et al. (2009) A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma. Nat Biotechnol 27: 264-274.
22. Haigis KM, Caya JG, Reichelderfer M, Dove WF (2002) Intestinal adenomas can develop with a stable karyotype and stable microsatellites. Proc Natl Acad Sci USA 99: 8927-8931. (Pubitemid 34693660)
23. Futreal PA, et al. (2004) A census of human cancer genes. Nat Rev Cancer 4:177-183. (Pubitemid 38337497)
24. Forbes S, et al. (2006) COSMIC 2005. Br J Cancer 94:318-322. (Pubitemid 43151554)
25. Vogelstein B, et al. (1989) Allelotype of colorectal carcinomas. Science 244:207-211. (Pubitemid 19110299)
26. Ried T, et al. (1996) Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 15:234-245. (Pubitemid 26115931)
27. Nakao K, et al. (2004) High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization. Carcinogenesis 25:1345-1357. (Pubitemid 39162701)
28. Habermann JK, et al. (2007) Stage-specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesis. Genes Chromosomes Cancer 46: 10-26. (Pubitemid 44772868)
29. Lassmann S, et al. (2007) Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas. J Mol Med 85:293-304.
30. Shih IM, et al. (2001) Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res 61:818-822.
31. Derks S, et al. (2008) Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations. Carcinogenesis 29:434-439. (Pubitemid 351359685)
32. Kurashina K, et al. (2008) Chromosome copy number analysis in screening for prognosis-related genomic regions in colorectal carcinoma. Cancer Sci 99:1835-1840.
33. Kemp Z, et al.; ColoRectal tumour Gene Identification (CoRGI) Study Consortium (2006) Evidence for a colorectal cancer susceptibility locus on chromosome 3q21-q24 from a high-density SNP genome-wide linkage scan. Hum Mol Genet 15:2903-2910. (Pubitemid 44458121)
34. Neklason DW, et al. (2008) Common familial colorectal cancer linked to chromosome 7q31: A genome-wide analysis. Cancer Res 68:8993-8997.
35. Nishisho I, et al. (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253:665-669. (Pubitemid 21917200)
36. Winkler GS, Mulder KW, Bardwell VJ, Kalkhoven E, Timmers HT (2006) Human Ccr4- Not complex is a ligand-dependent repressor of nuclear receptor-mediated transcription. EMBO J 25:3089-3099. (Pubitemid 44106761)
37. Cho NL, Javid SH, Carothers AM, Redston M, Bertagnolli MM (2007) Estrogen receptors alpha and beta are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/+ mice. Cancer Res 67:2366-2372. (Pubitemid 46437055)
38. Cleveland AG, et al. (2009) Disruption of estrogen receptor signaling enhances intestinal neoplasia in Apc(Min/+) mice. Carcinogenesis 30:1581-1590.
39. Odorizzi G (2006) The multiple personalities of Alix. J Cell Sci 119:3025-3032. (Pubitemid 44322116)
40. Vito P, Lacanà E, D'Adamio L (1996) Interfering with apoptosis: Ca(2+)-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 271:521-525.
41. Schmidt MH, et al. (2004) Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex. Mol Cell Biol 24:8981-8993. (Pubitemid 39313903)
42. Wu X, Li Y, Crise B, Burgess SM (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science 300:1749-1751. (Pubitemid 36712571)